Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor activity-modifying protein 2 (RAMP2) is an accessory membrane protein that interacts with and modulates the function of several G-protein coupled receptors (GPCRs), particularly those in the class B family. RAMP2 is essential for determining receptor pharmacology, trafficking, and signaling specificity. It primarily functions by allosterically binding to certain GPCRs, such as the glucagon receptor (GCGR) or the calcitonin receptor-like receptor (CALCRL), influencing their trafficking, localization, and signaling properties. It plays a critical role in cardiovascular physiology, and its loss-of-function can result in severe defects.
Modulates ligand selectivity, regulates endocytic trafficking, and alters intracellular retention and recycling dynamics of target GPCRs, influencing their signaling bias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor Activity-Modifying Protein 2.